Radiology practice SimonMed Imaging launches new ‘longevity screening’ division
Scottsdale, Arizona-based radiology practice SimonMed Imaging on Monday launched a new division focused on helping patients prolong their lives.
Dubbed “SimonMed Longevity,” the business line offers different tiers of elective MRI exams interpreted by its staff of over 200 radiologists. Packages range from an $899, 30-minute “Core MRI” focused on the chest, abdomen and pelvis up to a $2,199, hour-long option that also covers the head, neck and spine.
SimonMed first introduced its whole-body scan service in 2023—influenced at least partly by competitor Prenuvo—and has sought to expand since amid strong interest. The elective exams have previously been delivered under the SimonONE brand and will be folded into the rest of the radiology practice for greater service integration.
“Bringing Longevity under SimonMed allows us to scale preventive care more effectively and deliver a more seamless experience for patients and providers,” Founder and CEO John Simon, MD, said in a Jan. 26 announcement. “Preventive imaging shouldn’t be a standalone offering—it should be part of routine healthcare.”
SimonMed said the rebrand reflects a “strategic evolution” in its approach to preventive care. As part of this shift, the practice plans to increase its utilization of artificial intelligence to bolster earlier detection of disease risk and preventive care support, alongside the company’s core diagnostic services. SimonMed Longevity will incorporate other modalities into the division, including CT, ultrasound and mammography.
Consumers also can receive lab work, clinical consultations, integrated follow-up imaging and “AI powered” healthcare action plans. The services appear to be influenced by competitor Function Health, another celebrity-backed longevity firm like Prenuvo, that recently expanded into whole-body screening with the acquisition of Ezra. SimonMed said it will initially launch longevity services across 30 of its locations nationwide with plans to expand availability to more than 70 sites by April.
During a transition period, SimonONE will remain available at select locations. The practice currently operates about 170 total outpatient centers spanning 10 states and is backed by private equity firm American Securities.
“This evolution isn’t about changing who we are,” Chief Marketing Officer Jenna Lloyd said in the announcement. “It’s about building on our expertise in response to what patients are asking for—a clearer understanding of their health, and what to do about it, so they can live healthier, longer lives.”
Marty Stempniak has covered healthcare since 2012, with his byline appearing in the American Hospital Association's member magazine, Modern Healthcare and McKnight's. Prior to that, he wrote about village government and local business for his hometown newspaper in Oak Park, Illinois. He won a Peter Lisagor and Gold EXCEL awards in 2017 for his coverage of the opioid epidemic.